LEVETIRACETAM DEXCEL 750

Pays: Israël

Langue: anglais

Source: Ministry of Health

Ingrédients actifs:

LEVETIRACETAM

Disponible depuis:

DEXCEL PHARMA TECHNOLOGIES LTD

Code ATC:

N03AX14

forme pharmaceutique:

TABLETS

Composition:

LEVETIRACETAM 750 MG

Mode d'administration:

PER OS

Type d'ordonnance:

Required

Fabriqué par:

DEXCEL LTD, ISRAEL

Groupe thérapeutique:

LEVETIRACETAM

Domaine thérapeutique:

LEVETIRACETAM

indications thérapeutiques:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Date de l'autorisation:

2018-03-31